Fred Eshelman

Chief Executive Officer at Innocrin Pharmaceuticals, Inc.

Fred Eshelman

Fred Eshelman

Chief Executive Officer at Innocrin Pharmaceuticals, Inc.

Overview
Career Highlights

The Medicines Co.
Furiex Pharmaceuticals Inc.
Innocrin Pharmaceuticals, Inc.

RelSci Relationships

2274

Number of Boards

32

Birthday

1949 - High Point, NC, United States

Age

71

Number of Awards

1

Relationships
RelSci Relationships are individuals Fred Eshelman likely has professional access to. A relationship does not necessarily indicate a personal connection.

Former President, Chief Executive Officer, Director at Innocrin Pharmaceuticals, Inc.

Relationship likelihood: Strong

President & Chief Executive Officer at Vizuri Health Sciences LLC

Relationship likelihood: Strong

General Partner at Hatteras Venture Partners

Relationship likelihood: Strong

Founder & Managing Director at Lilly Ventures Management Co. LLC

Relationship likelihood: Strong

President at Maverick Label

Relationship likelihood: Strong

Vice President Revenue Cycle at Trinity Mother Frances Health System

Relationship likelihood: Strong

Venture Partner at Pappas Capital LLC

Relationship likelihood: Strong

CIO at Lurie Investments

Relationship likelihood: Strong

Founder at Eyenovia, Inc.

Relationship likelihood: Strong

Dean of the School of Medicine at The University of North Carolina at Chapel Hill

Relationship likelihood: Strong

Paths to Fred Eshelman
Potential Connections via
Relationship Science
You
Fred Eshelman
Chief Executive Officer at Innocrin Pharmaceuticals, Inc.
Education
PharmD
Class of 1972

The UNC Eshelman School of Pharmacy is located at the University of North Carolina at Chapel Hill. The school's doctor of pharmacy program was ranked second among pharmacy schools in the United States in 2012 by the U.S. News & World Report. The school was founded in 1897 and is one of the oldest schools of pharmacy in the nation. It is accredited by the American Council for Pharmacy Education and is a member of the American Association of Colleges of Pharmacy. The School educates approximately 550 professional students and 100 graduate students, postdocs, residents, and fellows each year.

Doctorate of Pharmacy

University of Cincinnati is a comprehensive public research university in Cincinnati, in the U.S. state of Ohio, and a part of the University System of Ohio. Founded in 1819 as Cincinnati College, it is the oldest institution of higher education in Cincinnati and has an annual enrollment of over 40,000 students, making it the second largest university in Ohio and one of the largest universities in the United States.

The University of North Carolina at Chapel Hill also known as UNC, UNC-Chapel Hill, Chapel Hill, North Carolina, or simply Carolina is a coeducational public research university located in Chapel Hill, North Carolina, United States. North Carolina has been consistently ranked among the highest ranked universities in the United States and is one of the original eight Public Ivy schools that provide an Ivy League experience for a public schooling price. After being chartered in 1789, the university first began enrolling students in 1795, which allows it to be one of three schools to claim the title of the oldest public university in the United States.

Owner President Management Program

Harvard Business School (HBS) is the graduate business school of Harvard University in Boston, Massachusetts, United States. The school offers a large full-time MBA program, doctoral programs, and many executive education programs. It owns Harvard Business School Publishing, which publishes business books, leadership articles, online management tools for corporate learning, case studies, and the monthly Harvard Business Review.

Career History
Chief Executive Officer
Prior - 1989

PPD Development provides drugs and medicine production services. The company offers para pharmaceutical production services, biochemical and biotechnology production, and rubber production services. The company is headquartered in Wilmington, NC.

Senior Vice President, Development & Director
Prior

Glaxo Inc.is the right arm of GlaxoSmithKline. In 1983 the American arm, Glaxo Inc., moved to Research Triangle Park (US headquarters/research) and Zebulon (US manufacturing) in North Carolina.

Founder
Prior - 2011

Pharmaceutical Product Development LLC engages in the operation of a global contract research organization, which provides drug development, laboratory and lifecycle management services. It offers adaptive trial design, bio analytical lab, bio similar development, biostatistics, GMP lab, clinical supplies, trial monitoring, CMC regulatory, data management, dental pain clinic, real-world outcomes, site intelligence and activation, central lab, global regulatory affairs, IRT systems, late stage research, medical communications, device and diagnostics, medical writing, nonclinical development and regulatory consulting and intelligence, regulatory development, innovation and vaccine sciences. The company was founded by Fredric N. Eshelman in 1985 and is headquartered in Wilmington, NC.

Boards & Committees
Chairman, Board of Directors
2020 - Current

Aravive, Inc. is a clinical-stage biotechnology company, which engages in developing new therapies that target important survival pathways for both advanced solid tumors as well as hematologic malignancies. Its product candidate, Aravive-S6, is a soluble Fc-fusion protein designed to block the activation of the GAS6-AXL signaling pathway by intercepting the binding of GAS6 to its receptor AXL which also promotes metastasis, cancer cell survival, resistance to treatments, and immune suppression. The company was founded on December 10, 2008 and is headquartered in Houston, TX.

Independent Director
2019 - Current

Amplitude Healthcare Acquisition Corp. operates as a blank check company. It aims to acquire one or more businesses and assets through a merger, share purchase and reorganization. The company was founded on August 13, 2019 and is headquartered in New York, NY.

Chairman of the Board
2018 - Current

Eyenovia, Inc. is a clinical stage biopharmaceutical company, which engages in the research and development of ophthalmology products. The company offers a piezo-print technology to deliver micro-doses of micro-therapeutics for the eyes. Its products include MicroProst, MicroStat, MicroTears, and MicroPine. The firm is currently focused on the late-stage development of microdosed medications for presbyopia, myopia progression and mydriasis. The company was founded by Sean Ianchulev on March 12, 2014 and is headquartered in New York, NY.

Chairman
Current

Started in 2008, the Eshelman Foundation is a private family foundation that aims to help children in need. Based in Wilmington, NC the Eshelman Foundation focuses on children's healthcare and educational causes in the United States.

Member, Board of Visitors
Current

The UNC Eshelman School of Pharmacy is located at the University of North Carolina at Chapel Hill. The school's doctor of pharmacy program was ranked second among pharmacy schools in the United States in 2012 by the U.S. News & World Report. The school was founded in 1897 and is one of the oldest schools of pharmacy in the nation. It is accredited by the American Council for Pharmacy Education and is a member of the American Association of Colleges of Pharmacy. The School educates approximately 550 professional students and 100 graduate students, postdocs, residents, and fellows each year.

Member-Governors Board
Current
Non-Profit Donations & Grants

Learn how non-profit organizations benefit from RelSci
$100M
2014

The UNC Eshelman School of Pharmacy is located at the University of North Carolina at Chapel Hill. The school's doctor of pharmacy program was ranked second among pharmacy schools in the United States in 2012 by the U.S. News & World Report. The school was founded in 1897 and is one of the oldest schools of pharmacy in the nation. It is accredited by the American Council for Pharmacy Education and is a member of the American Association of Colleges of Pharmacy. The School educates approximately 550 professional students and 100 graduate students, postdocs, residents, and fellows each year.

$3M
2014

The University of North Carolina at Chapel Hill also known as UNC, UNC-Chapel Hill, Chapel Hill, North Carolina, or simply Carolina is a coeducational public research university located in Chapel Hill, North Carolina, United States. North Carolina has been consistently ranked among the highest ranked universities in the United States and is one of the original eight Public Ivy schools that provide an Ivy League experience for a public schooling price. After being chartered in 1789, the university first began enrolling students in 1795, which allows it to be one of three schools to claim the title of the oldest public university in the United States.

$2.5M
2012

The University of North Carolina at Chapel Hill also known as UNC, UNC-Chapel Hill, Chapel Hill, North Carolina, or simply Carolina is a coeducational public research university located in Chapel Hill, North Carolina, United States. North Carolina has been consistently ranked among the highest ranked universities in the United States and is one of the original eight Public Ivy schools that provide an Ivy League experience for a public schooling price. After being chartered in 1789, the university first began enrolling students in 1795, which allows it to be one of three schools to claim the title of the oldest public university in the United States.

Political Donations
$5,000
2015

Senator from North Carolina

$10K
2014

Senator at Office of the Senator from North Carolina, Thom Tillis

Transactions
Details Hidden

Innocrin Pharmaceuticals Holdings LLC raised money in a private placement transaction

Details Hidden

Corinthian Ophthalmic, Inc. raised money in a private placement transaction

Investments
Details Hidden

Furiex Pharmaceuticals, Inc. is a drug development collaboration company using innovative clinical development strategies to accelerate and increase the value of partnered drug programs by advancing them through development in a cost-efficient manner. As the biopharmaceutical industry faces increased R&D spending with fewer successful therapies reaching the market, Furiex offers a new approach to help drug developers lower development costs and deliver products to the market more efficiently

Public Holdings
Restricted data only for RelSci Professional users.
Awards & Honors
Rank #20
2014
The Chronicle of Philanthropy - Philanthropy 50
Other Affiliations

Fred Eshelman is affiliated with PPD Development LP, Glaxo, Inc., Pharmaceutical Product Development LLC, Corinthian Ophthalmic, Inc., University of North Carolina at Chapel Hill - School of Pharmacy, Eshelman Ventures LLC, The Medicines Co., Furiex Pharmaceuticals Inc., Accelerator Services Corp., Boehringer Mannheim Pharmaceuticals Corp., Harvard University - Harvard Business School, Pharmaceutical Product Development, Inc., Innocrin Pharmaceuticals Holdings LLC, Innocrin Pharmaceuticals, Inc., Aravive, Inc., Amplitude Healthcare Acquisition Corp., Eyenovia, Inc., Asepticys LLC, Cellective Biotherapy, Inc., G1 Therapeutics, Inc., Medikidz USA, Inc., Dignify Therapeutics LLC, Innocrin Pharmaceuticals Holdings LLC, Princeton Biopharma Capital Partners, LLC, Aero MD, Auven Therapeutics Management LLLP, Bausch Health Cos., Inc., Furiex Pharmaceuticals Inc., Pharmaceutical Product Development LLC, Pharmaceutical Product Development, Inc., Aton Pharma, Inc., Kinnate Biopharma, Inc., Accelerator Services Corp., XORI Corp., Meryx, Inc., Corinthian Ophthalmic, Inc., Neoantigenics, Inc., Innocrin Pharmaceuticals, Inc., The Eshelman Foundation, University of North Carolina at Chapel Hill - School of Pharmacy, North Carolina School of Science & Mathematics, University of North Carolina System, The Medicines Co., The North Carolina Biotechnology Center, The University of North Carolina at Wilmington, Medical Foundation of North Carolina, Inc., Association of Clinical Research Organizations

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Fred Eshelman. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Fred Eshelman's profile does not indicate a business or promotional relationship of any kind between RelSci and Fred Eshelman.